Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$32.73 - $47.95 $2.08 Million - $3.04 Million
-63,423 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$40.39 - $56.73 $54,849 - $77,039
1,358 Added 2.19%
63,423 $2.84 Million
Q4 2020

Feb 16, 2021

BUY
$51.77 - $66.18 $2,899 - $3,706
56 Added 0.09%
62,065 $3.54 Million
Q3 2020

Nov 12, 2020

BUY
$43.8 - $58.16 $36,835 - $48,912
841 Added 1.37%
62,009 $3.18 Million
Q2 2020

Jul 30, 2020

BUY
$37.05 - $65.03 $318,592 - $559,192
8,599 Added 16.36%
61,168 $3.65 Million
Q1 2020

May 07, 2020

BUY
$33.63 - $69.4 $1,748 - $3,608
52 Added 0.1%
52,569 $2.16 Million
Q4 2019

Feb 07, 2020

BUY
$31.7 - $69.93 $33,792 - $74,545
1,066 Added 2.07%
52,517 $3.27 Million
Q3 2019

Nov 12, 2019

BUY
$19.95 - $38.85 $1.03 Million - $2 Million
51,451 New
51,451 $1.75 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.